More stories

Psychedelic Bulletin #114 – Lawsuit Alleges Compass Stole Trade Secrets; MindMed CMO Turns Activist...

This Week: Lawsuit alleges Compass Pathways “milked” researcher for trade secrets before “secretly” filing patent on same technology Exclusive: Tweet from Compass Account Calls...

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Blue Serenity brings science and compassion together, will cement Thomas Hartle’s legacy as a Canadian psychedelic icon Optimi and Hartle to host press conference...

MindMed Strengthens Board with Appointment of Two New Independent Directors

NEW YORK, Aug. 12, 2022 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company”), a clinical stage biopharmaceutical company developing novel...

Opinions | Hallucinations of Meaning: If you can lie, so can psychedelics

– Abigail Caulder – A common first sign of a psychedelic taking effect is the feeling that something important is happening. There is a...

PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act, and the Magic...

In this episode, David Drapkin interviews Kevin Balktick: Founder and Director of Horizons; one of the world's longest-running psychedelic media, education, and communities –...

MindMed Reports Second Quarter 2022 Financial Results and Business Highlights

– Phase 2b dose-optimization trial in patients with General Anxiety Disorder underway with first patient dosing expected in Q3 2022 – – Advanced IND-enabling...

Can Psilocybin Treat Obesity? New Evidence, Future Directions

Obesity is a worldwide health concern – the World Health Organization reports 39% of adults globally are overweight, and 13% are considered obese. 1...

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

PSIL-001 and PSIL-002 show promising antidepressant effects without hallucinations while having improved learning and memory tendencies over a psilocybin mimic TAMPA, Fla., Aug. 10,...

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and...

PsyBio Therapeutics Announces Expansion of Patent Portfolio with Additional Global Patent Applications

PsyBio is continuing to increase its psycho-targeted patent portfolio, executing on its strategic priorities of innovation, development, and technology optimization PsyBio now has twenty...

Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle

VANCOUVER, British Columbia, Aug. 08, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown,...

PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations

In this episode of the podcast, Kyle Buller returns with another episode of Vital Psychedelic Conversations – this time with past guest Steve Thayer:...

Most popular